Hudson Bay Capital Management LP 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-10 1:58 pm Sale | 2023-09-30 | 13G | Calidi Biotherapeutics, Inc. CLDI | Hudson Bay Capital Management LP | 0 0.000% | -50,000 (Position Closed) | Filing |
| 2022-11-08 4:05 pm Purchase | 2022-10-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | Hudson Bay Capital Management LP | 50,000 12.110% | 50,000 (New Position) | Filing |